1. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9 (September 2019) Authors: Ratjen, Felix; Davis, Stephanie D; Stanojevic, Sanja; Kronmal, Richard A; Hinckley Stukovsky, Karen D; Jorgensen, Neal; Rosenfeld, Margaret; Kerby, Gwen; Kopecky, Carol; Anthony, Meg; Mogayzel, Peter; Walker, Doug; Zeglin, Britany; Hoover, Wynton; Hathorne, Heather; Slaten, Katie; Dorkin, Henry (... Journal: Lancet Issue: Volume 7:Issue 9(2019) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. Issue 7 (July 2018) Authors: Rosenfeld, Margaret; Wainwright, Claire E.; Higgins, Mark; Wang, Linda T.; McKee, Charlotte; Campbell, Daniel; Tian, Simon; Schneider, Jennifer; Cunningham, Steve; Davies, Jane C.; Harris, William; Mogayzel, Peter; McCoy, Karen; Milla, Carlos; Rubenstein, Ronald; Walker, Seth; Black, Philip; Mont... Journal: Lancet Issue: Volume 6:Issue 7(2018) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗